Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
3,428 studies for “Sanofi”
- Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host DiseaseRecruiting
Sponsor: Fred Hutchinson Cancer Center
Chronic Graft Versus Host Disease
United States
Sponsor: Sanofi Pasteur, a Sanofi Company
Acne
United States, Australia, Canada, Puerto Rico
- BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR)Active Not Recruiting
Sponsor: Sanofi
Transplant Rejection
United States, Canada, France, Germany, Italy +2 more
Sponsor: Sanofi
Autoimmune Haemolytic Anaemia
United States, Argentina, Austria, Brazil, China +12 more
Sponsor: Sanofi
Healthy Volunteers · Influenza
Sponsor: Sanofi
Ulcerative Colitis
United States, Bulgaria, Canada, China, Czechia +15 more
Sponsor: Regeneron Pharmaceuticals
Eosinophilic Esophagitis (EoE)
United States
- A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung CancerRecruiting
Sponsor: M.D. Anderson Cancer Center
Non-Small Cell Lung Cancer · ICI-refractory
United States
Sponsor: Sanofi
Hidradenitis Suppurativa
United States, Australia, Canada, Chile, China +14 more
Sponsor: Sanofi
Type 1 Diabetes
Kuwait, Saudi Arabia, United Arab Emirates
Sponsor: Sanofi
Ulcerative Colitis
United States, Canada, Georgia, Japan, Lithuania +3 more
Sponsor: Scleroderma Research Foundation, Inc.
Interstitial Lung Disease Due to Systemic Disease · Scleroderma
United States
Sponsor: Icahn School of Medicine at Mount Sinai
Asthma
United States
Sponsor: Sanofi
Chronic Graft Versus Host Disease
- Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple MyelomaActive Not Recruiting
Sponsor: University of Heidelberg Medical Center
Multiple Myeloma
Austria, Germany
- A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.Active Not Recruiting
Sponsor: Sanofi
Relapsing Multiple Sclerosis · Secondary Progressive Multiple Sclerosis · Progressive Relapsing Multiple Sclerosis
United States, Argentina, Australia, Austria, Belgium +42 more
- Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes InfectionCompleted
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Healthy Volunteers
United States
Sponsor: Sanofi
Hemophilia
United States, Belgium, Brazil, Canada, China +8 more
Sponsor: American Thrombosis and Hemostasis Network
Hematologic Disorder · Bleeding Disorder · Connective Tissue Disorder · Hemophilia
United States
Sponsor: Sanofi
Multiple Sclerosis
United States, Belgium, China, Italy, Japan
Sponsor: Sanofi
Neoplasm Malignant
United States, Czechia, Norway, South Korea, Spain
Sponsor: Centers for Disease Control and Prevention
Pulmonary Tuberculosis
United States, Brazil, Canada, South Africa, Spain +1 more
- Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With AsthmaEnrolling By Invitation
Sponsor: Sanofi
Asthma
United States, Argentina, Brazil, Canada, Chile +9 more
- Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)Enrolling By Invitation
Sponsor: Sanofi
Wheezing · Asthma
United States, Argentina, Brazil, Canada, Czechia +11 more
Sponsor: Sanofi
Asthma
United States, Canada, Japan
3,428 studies found